MedTrace Logo

Intracoronary ECG ST-segment Shift Remission Time During Reactive Coronary Hyperemia

NCT05583786 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-10-21

No results posted yet for this study

Summary

This study evaluates a new diagnostic approach based on intracoronary electrocardiogram (icECG) ST-segment shift remission time, denoted as τ-icECG (τ=tau, i.e., the remission half-time fitted by an exponential function to the disappearing ST-segment shift), to be used for PCI guidance.

Conditions

  • Chronic Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

Tracing intracoronary electrocardiogram

icECG ST-segment shift remission time (τ-icECG) tracing during reactive-hyperemia, obtained immediately after a 1-minute upstream coronary artery balloon occlusion.

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Christian Seiler, Prof · Inselspital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-09-30
Completion
2024-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05583786 on ClinicalTrials.gov